| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |